Sargent Bickham Lagudis’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$711K	Hold	9,523	–	–	0.06%	152
2022 Q3	$787K	Buy	9,523 +1	+0%	+$96	0.07%	140
2022 Q2	$905K	Buy	9,522 +234	+3%	+$24.2K	0.08%	140
2022 Q1	$1.09M	Sell	9,288 -600	-6%	-$67.3K	0.09%	132
2021 Q4	$1.28M	Hold	9,888	–	–	0.1%	119
2021 Q3	$1.12M	Sell	9,888 -864	-8%	-$98.6K	0.09%	124
2021 Q2	$1.11M	Sell	10,752 -48	-0.4%	-$4.52K	0.09%	124
2021 Q1	$903K	Hold	10,800	–	–	0.08%	121
2020 Q4	$985K	Sell	10,800 -195	-2%	-$16.2K	0.09%	119
2020 Q3	$878K	Hold	10,995	–	–	0.09%	117
2020 Q2	$760K	Hold	10,995	–	–	0.08%	120
2020 Q1	$691K	Buy	10,995 +6	+0.1%	+$433	0.09%	129
2019 Q4	$855K	Hold	10,989	–	–	0.09%	119
2019 Q3	$806K	Hold	10,989	–	–	0.1%	117
2019 Q2	$677K	Hold	10,989	–	–	0.08%	131
2019 Q1	$701K	Buy	10,989 +294	+3%	+$16.8K	0.08%	132
2018 Q4	$546K	Hold	10,695	–	–	0.07%	133
2018 Q3	$621K	Hold	10,695	–	–	0.07%	136
2018 Q2	$519K	Buy	10,695 +1,800	+20%	+$84K	0.06%	139
2018 Q1	$414K	Sell	8,895 -2,619	-23%	-$114K	0.05%	146
2017 Q4	$433K	Buy	11,514 +243	+2%	+$8.92K	0.05%	151
2017 Q3	$411K	Sell	11,271 -435	-4%	-$16.6K	0.05%	154
2017 Q2	$461K	Buy	11,706 +528	+5%	+$19.3K	0.06%	145
2017 Q1	$351K	Hold	11,178	–	–	0.05%	163
2016 Q4	$349K	Sell	11,178 -141	-1%	-$4.57K	0.05%	151
2016 Q3	$455	Sell	11,319 -180	-2%	-$6.78K	0.07%	140
2016 Q2	$382K	Buy	11,499 +141	+1%	+$4.82K	0.06%	148
2016 Q1	$334K	Buy	+11,358	New	+$313K	0.05%	160